Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 3
1977 2
1978 2
1979 4
1980 3
1981 1
1982 3
1983 5
1984 1
1985 5
1986 4
1987 1
1988 4
1989 3
1990 4
1991 6
1992 19
1993 11
1994 10
1995 9
1996 9
1997 5
1998 12
1999 10
2000 15
2001 10
2002 13
2003 10
2004 11
2005 10
2006 12
2007 11
2008 12
2009 5
2010 10
2011 16
2012 28
2013 21
2014 15
2015 22
2016 14
2017 20
2018 18
2019 15
2020 19
2021 15
2022 23
2023 16
2024 15
2025 20
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

504 results

Results by year

Filters applied: . Clear all
Page 1
Ataxia.
Ashizawa T, Xia G. Ashizawa T, et al. Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1208-26. doi: 10.1212/CON.0000000000000362. Continuum (Minneap Minn). 2016. PMID: 27495205 Free PMC article. Review.
Ataxia.
Akbar U, Ashizawa T. Akbar U, et al. Among authors: ashizawa t. Neurol Clin. 2015 Feb;33(1):225-48. doi: 10.1016/j.ncl.2014.09.004. Neurol Clin. 2015. PMID: 25432731 Free PMC article. Review.
Genetic ataxia.
Rosa AL, Ashizawa T. Rosa AL, et al. Among authors: ashizawa t. Neurol Clin. 2002 Aug;20(3):727-57, vii. doi: 10.1016/s0733-8619(02)00008-7. Neurol Clin. 2002. PMID: 12432828 Review.
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
Thornton CA, Moxley RT 3rd, Eichinger K, Heatwole C, Mignon L, Arnold WD, Ashizawa T, Day JW, Dent G, Tanner MK, Duong T, Greene EP, Herbelin L, Johnson NE, King W, Kissel JT, Leung DG, Lott DJ, Norris DA, Pucillo EM, Schell W, Statland JM, Stinson N, Subramony SH, Xia S, Bishop KM, Bennett CF. Thornton CA, et al. Among authors: ashizawa t. Lancet Neurol. 2023 Mar;22(3):218-228. doi: 10.1016/S1474-4422(23)00001-7. Lancet Neurol. 2023. PMID: 36804094 Clinical Trial.
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL. Zesiewicz TA, et al. Among authors: ashizawa t. Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9. Neurology. 2018. PMID: 29440566 Free PMC article.
Emerging therapies in hereditary ataxias.
Eisel MLS, Burns M, Ashizawa T, Byrne B, Corti M, Subramony SH. Eisel MLS, et al. Among authors: ashizawa t. Trends Mol Med. 2025 Feb;31(2):181-194. doi: 10.1016/j.molmed.2024.07.008. Epub 2024 Aug 16. Trends Mol Med. 2025. PMID: 39153956 Review.
Suicidal Ideation in Spinocerebellar Ataxia.
Peppel L, Lai RY, Rummey C, Opal P, Schmahmann JD, Gomez CM, Paulson H, Zesiewicz TA, Perlman S, Wilmot G, Ying SH, Onyike CU, Bushara KO, Geschwind MD, Figueroa KP, Pulst SM, Subramony SH, Duquette A, Ashizawa T, Hamedani AG, Davis MY, Srinivasan SR, Burns MR, Amokrane N, Moore LR, Shakkottai VG, Rosenthal LS, Kuo SH, Lin CR. Peppel L, et al. Among authors: ashizawa t. J Neuropsychiatry Clin Neurosci. 2026 Winter;38(1):38-44. doi: 10.1176/appi.neuropsych.20250006. Epub 2025 May 12. J Neuropsychiatry Clin Neurosci. 2026. PMID: 40350965 Free PMC article.
Spinocerebellar Ataxia Type 1.
Opal P, Ashizawa T. Opal P, et al. Among authors: ashizawa t. 1998 Oct 1 [updated 2023 Feb 2]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 1998 Oct 1 [updated 2023 Feb 2]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301363 Free Books & Documents. Review.
Spinocerebellar Ataxia Type 10.
Matsuura T, Ashizawa T. Matsuura T, et al. Among authors: ashizawa t. 2002 Apr 23 [updated 2019 Sep 19]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 2002 Apr 23 [updated 2019 Sep 19]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301354 Free Books & Documents. Review.
504 results